|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 9/00 | |
| A61K 31/5575 | |||
| A61K 47/36 | |||
| A61K 47/02 | |||
| A61K 31/5377 | |||
| A61K 31/728 | |||
| A61P 27/06 |
| (11) | Patento numeris | 2763654 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 12759652.6 |
| Europos patento paraiškos padavimo data | 2012-09-11 | |
| (97) | Europos patento paraiškos paskelbimo data | 2014-08-13 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2020-04-29 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/EP2012/003810 |
| Data | 2012-09-11 |
| (87) | Numeris | WO 2013/037479 |
| Data | 2013-03-21 |
| (30) | Numeris | Data | Šalis |
| 11306137 | 2011-09-12 | EP |
| (72) |
HADJ-SLIMANE, Réda, FR
|
| (73) |
Unither Pharmaceuticals,
151 rue André Durouchez CS 28028, 80084 Amiens Cedex 2,
FR
|
| (54) | OPHTHTALMIC COMPOSITIONS COMPRISING PROSTAGLANDIN F2 ALPHA DERIVATIVES AND HYALURONIC ACID |
| OPHTHTALMIC COMPOSITIONS COMPRISING PROSTAGLANDIN F2 ALPHA DERIVATIVES AND HYALURONIC ACID |